Robert M. Fielding

2.0k total citations
35 papers, 1.6k citations indexed

About

Robert M. Fielding is a scholar working on Infectious Diseases, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Robert M. Fielding has authored 35 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 9 papers in Pharmacology and 9 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Robert M. Fielding's work include Antifungal resistance and susceptibility (10 papers), Drug Transport and Resistance Mechanisms (8 papers) and Pharmaceutical studies and practices (8 papers). Robert M. Fielding is often cited by papers focused on Antifungal resistance and susceptibility (10 papers), Drug Transport and Resistance Mechanisms (8 papers) and Pharmaceutical studies and practices (8 papers). Robert M. Fielding collaborates with scholars based in United States, United Kingdom and India. Robert M. Fielding's co-authors include Donald N. Buell, Ihor Bekersky, Thomas J. Walsh, Dawna Dressler, Jean W. Lee, Philip C. Smith, Lanjun Guo, Luke S. S. Guo, L Moon-McDermott and Daniel Mufson and has published in prestigious journals such as Clinical Cancer Research, Annals of the New York Academy of Sciences and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Robert M. Fielding

33 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert M. Fielding United States	21	699	381	342	244	183	35	1.6k
R T Mehta United States	23	714 1.0×	522 1.4×	525 1.5×	77 0.3×	131 0.7×	39	1.7k
Dorothea Sesardic United Kingdom	32	372 0.5×	376 1.0×	963 2.8×	119 0.5×	386 2.1×	128	3.6k
Mohammad Husain India	26	691 1.0×	468 1.2×	865 2.5×	63 0.3×	147 0.8×	88	2.5k
Masataka Ichikawa Japan	25	210 0.3×	811 2.1×	638 1.9×	136 0.6×	250 1.4×	146	2.5k
Lisa M. Johansen United States	19	941 1.3×	389 1.0×	1.2k 3.5×	86 0.4×	293 1.6×	23	2.8k
Riad Agbaria Israel	27	447 0.6×	281 0.7×	774 2.3×	65 0.3×	291 1.6×	51	2.3k
Rob Webster United Kingdom	17	527 0.8×	200 0.5×	705 2.1×	62 0.3×	267 1.5×	26	2.1k
G. Lopez‐Berestein United States	17	267 0.4×	195 0.5×	548 1.6×	44 0.2×	222 1.2×	38	1.3k
Noha N. Salama United States	21	212 0.3×	127 0.3×	432 1.3×	151 0.6×	418 2.3×	41	1.5k
Sadhna Sharma India	30	600 0.9×	368 1.0×	708 2.1×	123 0.5×	116 0.6×	88	2.6k

Countries citing papers authored by Robert M. Fielding

Since Specialization

Citations

This map shows the geographic impact of Robert M. Fielding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert M. Fielding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert M. Fielding more than expected).

Fields of papers citing papers by Robert M. Fielding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert M. Fielding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert M. Fielding. The network helps show where Robert M. Fielding may publish in the future.

Co-authorship network of co-authors of Robert M. Fielding

This figure shows the co-authorship network connecting the top 25 collaborators of Robert M. Fielding. A scholar is included among the top collaborators of Robert M. Fielding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert M. Fielding. Robert M. Fielding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brenna, J. Thomas, Genevieve James, Mark Midei, et al.. (2020). Plasma and Red Blood Cell Membrane Accretion and Pharmacokinetics of RT001 (bis-Allylic 11,11-D2-Linoleic Acid Ethyl Ester) during Long Term Dosing in Patients. Journal of Pharmaceutical Sciences. 109(11). 3496–3503. 16 indexed citations

Burch, Daniel, et al.. (2013). Lack of tyramine pressor response effect with oral CX157: A specific reversible MAOI. Clinical Pharmacology in Drug Development. 3(1). 4–12. 2 indexed citations

Drappatz, Jan, Andrew Brenner, Eric T. Wong, et al.. (2013). Phase I Study of GRN1005 in Recurrent Malignant Glioma. Clinical Cancer Research. 19(6). 1567–1576. 143 indexed citations

Issell, Brian F., Adrian A. Franke, & Robert M. Fielding. (2008). Pharmacokinetic Study of Noni Fruit Extract. Journal of Dietary Supplements. 5(4). 373–382. 20 indexed citations

Zacharia, Lefteris C., Claude A. Piché, Robert M. Fielding, et al.. (2004). 2-Hydroxyestradiol Is a Prodrug of 2-Methoxyestradiol. Journal of Pharmacology and Experimental Therapeutics. 309(3). 1093–1097. 40 indexed citations

Bekersky, Ihor, et al.. (2001). Pharmacokinetics, Excretion, and Mass Balance of ¹⁴C after Administration of ¹⁴C‐Cholesterol‐Labeled AmBisome to Healthy Volunteers. The Journal of Clinical Pharmacology. 41(9). 963–971.

Fielding, Robert M.. (2001). Relationship of Pharmacokinetically-Calculated Volumes of Distribution to the Physiologic Distribution of Liposomal Drugs in Tissues: Implications for the Characterization of Liposomal Formulations. Pharmaceutical Research. 18(2). 238–242. 11 indexed citations

Bekersky, I, Robert M. Fielding, Dawna Dressler, et al.. (2001). Pharmacokinetics, Excretion, and Mass Balance of <SUP>14</SUP>C after Administration of <SUP>14</SUP>C-Cholesterol-Labeled AmBisome to Healthy Volunteers. The Journal of Clinical Pharmacology. 41(9). 963–971. 27 indexed citations

Bekersky, Ihor, et al.. (1999). Safety and Toxicokinetics of Intravenous Liposomal Amphotericin B (AmBisome ®) in Beagle Dogs. Pharmaceutical Research. 16(11). 1694–1701. 48 indexed citations

10.

Fielding, Robert M., et al.. (1999). Bioavailability of a Small Unilamellar Low-Clearance Liposomal Amikacin Formulation after Extravascular Administration. Journal of drug targeting. 6(6). 415–426. 7 indexed citations

11.

Fielding, Robert M., et al.. (1999). Pharmacokinetics and Urinary Excretion of Amikacin in Low-Clearance Unilamellar Liposomes after a Single or Repeated Intravenous Administration in the Rhesus Monkey. Antimicrobial Agents and Chemotherapy. 43(3). 503–509. 32 indexed citations

12.

Fielding, Robert M., et al.. (1998). Altered Tissue Distribution and Elimination of Amikacin Encapsulated in Unilamellar, Low-Clearance Liposomes (MiKasome®). Pharmaceutical Research. 15(11). 1775–1781. 53 indexed citations

13.

Fielding, Robert M., et al.. (1995). Comparative Tissue Distribution and Elimination of Amphotericin B Colloidal Dispersion (Amphocil®) and Fungizone® After Repeated Dosing in Rats. Pharmaceutical Research. 12(2). 275–283. 48 indexed citations

14.

Fielding, Robert M. & R.M. Abra. (1992). Factors Affecting the Release Rate of Terbutaline from Liposome Formulations After Intratracheal Instillation in the Guinea Pig. Pharmaceutical Research. 9(2). 220–223. 32 indexed citations

15.

Smith, Philip C., et al.. (1992). High-performance liquid chromatographic analysis of amphotericin B in plasma, blood, urine and tissues for pharmacokinetic and tissue distribution studies. Journal of Chromatography B Biomedical Sciences and Applications. 579(2). 259–268. 32 indexed citations

16.

Fielding, Robert M.. (1991). Liposomal Drug Delivery. Clinical Pharmacokinetics. 21(3). 155–164. 96 indexed citations

17.

Waschek, James A., Robert M. Fielding, Thomas N. Tozer, David J. Effeney, & Susan M. Pond. (1988). Time-dependent, plasma-sulfate-independent kinetics of salicylamide in dogs. Journal of Pharmacokinetics and Biopharmaceutics. 16(2). 151–159.

18.

Fielding, Robert M., James A. Waschek, David J. Effeney, et al.. (1986). Extrahepatic extraction of salicylamide in dogs.. Journal of Pharmacology and Experimental Therapeutics. 236(1). 97–102. 5 indexed citations

19.

Waschek, James A., Robert M. Fielding, Susan M. Pond, et al.. (1985). Dose-dependent sulfoconjugation of salicylamide in dogs: effect of sulfate depletion or administration.. Journal of Pharmacology and Experimental Therapeutics. 234(2). 431–434. 13 indexed citations

20.

Fielding, Robert M., James A. Waschek, Gerald M. Rubin, Susan M. Pond, & T N Tozer. (1984). Analysis of Salicylamide and Its Metabolites in Blood and Urine by HPLC. Journal of Liquid Chromatography. 7(6). 1221–1234. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact